89 related articles for article (PubMed ID: 7458073)
1. Effects of C5a on baboon alveolar macrophage migration.
Fine R; Shaw JO; Rogers WR
Am Rev Respir Dis; 1981 Jan; 123(1):110-14. PubMed ID: 7458073
[TBL] [Abstract][Full Text] [Related]
2. Complement fragments, alveolar macrophages, and alveolitis.
Henson PM; McCarthy K; Larsen GL; Webster RO; Giclas PC; Dreisin RB; King TE; Shaw JO
Am J Pathol; 1979 Oct; 97(1):93-110. PubMed ID: 495697
[TBL] [Abstract][Full Text] [Related]
3. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary defense mechanisms: modulation of Fc receptor activity in alveolar macrophages and other phagocytic cells by N-formyl peptides.
Rossman MD; Cassizzi AM; Schreiber AD; Daniele RP
Am Rev Respir Dis; 1982 Jul; 126(1):136-41. PubMed ID: 7201286
[TBL] [Abstract][Full Text] [Related]
5. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Russ WD; Thomas KR; Rasmussen JK; Kay HD
Am Rev Respir Dis; 1987 Mar; 135(3):659-64. PubMed ID: 3826892
[TBL] [Abstract][Full Text] [Related]
6. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
Kazmierowski JA; Gallin JI; Reynolds HY
J Clin Invest; 1977 Feb; 59(2):273-81. PubMed ID: 401834
[TBL] [Abstract][Full Text] [Related]
7. Time course of chemotactic factor generation and the corresponding macrophage response to asbestos inhalation.
Warheit DB; Hill LH; George G; Brody AR
Am Rev Respir Dis; 1986 Jul; 134(1):128-33. PubMed ID: 3729150
[TBL] [Abstract][Full Text] [Related]
8. In vitro activation of rat neutrophils and alveolar macrophages with IgA and IgG immune complexes. Implications for immune complex-induced lung injury.
Warren JS; Kunkel SL; Johnson KJ; Ward PA
Am J Pathol; 1987 Dec; 129(3):578-88. PubMed ID: 2827492
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
[TBL] [Abstract][Full Text] [Related]
10. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
Daughaday CC; Mehta J; Spilberg I; Atkinson JP
J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
[TBL] [Abstract][Full Text] [Related]
11. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
Charo IF; Yuen C; Perez HD; Goldstein IM
J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
[TBL] [Abstract][Full Text] [Related]
12. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
[TBL] [Abstract][Full Text] [Related]
14. Induction of lysosomal enzyme secretion by alveolar macrophages in response to the purified complement fragments C5a and C5a des-arg.
McCarthy K; Henson PM
J Immunol; 1979 Dec; 123(6):2511-7. PubMed ID: 574148
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor.
Gadek JE; Hunninghake GW; Zimmerman RL; Crystal RG
Am Rev Respir Dis; 1980 Apr; 121(4):723-33. PubMed ID: 6992662
[TBL] [Abstract][Full Text] [Related]
16. Alveolar macrophage function and inflammatory stimuli in smokers with and without obstructive lung disease.
McLeod R; Mack DG; McLeod EG; Campbell EJ; Estes RG
Am Rev Respir Dis; 1985 Mar; 131(3):377-84. PubMed ID: 2983591
[TBL] [Abstract][Full Text] [Related]
17. Impaired alveolar macrophage chemotaxis in patients with acute smoke inhalation.
Demarest GB; Hudson LD; Altman LC
Am Rev Respir Dis; 1979 Feb; 119(2):279-86. PubMed ID: 434600
[TBL] [Abstract][Full Text] [Related]
18. Production of cyclooxygenase products and superoxide anion by macrophages in response to chemotactic factors.
Kunkel SL; Kaercher K; Plewa M; Fantone JC; Ward PA
Prostaglandins; 1982 Dec; 24(6):789-99. PubMed ID: 6300969
[TBL] [Abstract][Full Text] [Related]
19. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
Senior RM; Griffin GL; Perez HD; Webster RO
J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
[TBL] [Abstract][Full Text] [Related]
20. Determination of a specific receptor for formyl-methionyl-leucyl-phenylalanine on th pulmonary alveolar macrophage and its relationship to chemotaxis and superoxide production.
Spilberg I; Mehta J; Daughaday C; Simchowitz L
J Lab Clin Med; 1981 May; 97(5):602-9. PubMed ID: 6260878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
